Señales en vivo de QLGN | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 abr 2024 @ 16:00):

Qualigen Therapeutics, Inc., a biotechnology company, develops novel therapeutic products for the treatment of cancer and infectious diseases. It offers FastPack, a rapid diagnostic testing system...

Stats
Volumen de hoy	9 087.00
Volumen promedio	65 834.00
Capitalización de mercado	1.83M
EPS	$-0.640 ( 2023-11-14 )
Próxima fecha de ganancias	( $-0.520 ) 2024-05-21
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.120
ATR14	$0.00700 (2.41%)

Insider Trading

Date	Person	Action	Amount	type
2022-07-11	Abdul-ahad Wajdi	Buy	80 000	Stock Option (Right to Buy)
2022-07-11	Lotz Christopher L.	Buy	100 000	Stock Option (Right to Buy)
2022-07-11	Lotz Christopher L.	Buy	100 000	Stock Option (Right to Buy)
2022-07-11	Arshad Tariq	Buy	102 000	Stock Option (Right to Buy)
2022-07-11	Ritter Ira E.	Buy	40 000	Stock Option (Right to Buy)

INSIDER POWER
100.00
Last 89 transactions
Buy: 8 588 032 \| Sell: 1 076 061

Qualigen Therapeutics Inc Correlación

10 Correlaciones Más Positivas
LYEL	0.959
ARQQ	0.958
WISA	0.956
FATE	0.954
QTEK	0.953
RPID	0.953
STRC	0.951
NKTX	0.951
LYRA	0.945
GROM	0.944

10 Correlaciones Más Negativas
LRFC	-0.955
NWFL	-0.954
STAY	-0.944
LUNA	-0.941
TIPT	-0.939
IBEX	-0.938
IVAC	-0.936
PEBK	-0.935
GLLI	-0.931
CCRC	-0.931

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Qualigen Therapeutics Inc Finanzas

Annual	2023
Ingresos:	$0
Beneficio Bruto:	$-4 495.00 (0.00 %)
EPS:	$-2.53

FY	2023
Ingresos:	$0
Beneficio Bruto:	$-4 495.00 (0.00 %)
EPS:	$-2.53

FY	2022
Ingresos:	$4.98M
Beneficio Bruto:	$680 801 (13.66 %)
EPS:	$-5.48

FY	2021
Ingresos:	$5.65M
Beneficio Bruto:	$1.32M (23.37 %)
EPS:	$-6.10

Financial Reports:

No articles found.

Qualigen Therapeutics Inc

Qualigen Therapeutics, Inc., a biotechnology company, develops novel therapeutic products for the treatment of cancer and infectious diseases. It offers FastPack, a rapid diagnostic testing system. The company is developing QN-302 for the treatment of pancreatic ductal adenocarcinoma; QN-247, a DNA coated gold nanoparticle cancer drug candidate that targets various cancers; RAS-F, a small-molecule RAS oncogene protein-protein inhibitor that blocks RAS mutations and inhibits tumor formation; and STARS blood cleansing system, a DNA/RNA-based treatment device that removes tumor-produced compounds and viruses from a patient's blood. Qualigen Therapeutics, Inc. was founded in 1996 and is based in Carlsbad, California.